Renagel® efficacy in severe secondary hyperparathyroidism R. CASTRO , A. HERMAN , C. FERREIRA , F. TRAVASSOS , M. OLIVEIRA , J. NÚÑEZ

Fuller Albright and our current understanding of calcium and phosphorus regulation and primary hyperparathyroidism Felsenfeld, Levine, Kleeman

Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism Angel Luis Martín de Francisco, Iain Andrew Gillespie, Ioanna Gioni, Jürgen Floege, Florian Kronenberg, Daniele Marcelli, David Collins. Wheeler, Marc Froissart, Tilman Bernhard. Drueke